Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Adjuvant therapy for pancreatic adenocarcinoma.

Abrams RA.

J Gastrointest Surg. 2001 Jan-Feb;5(1):6-7. Review. No abstract available.

PMID:
11370618
2.

Novel approaches to postoperative chemoradiation therapy in pancreatic cancer.

Picozzi VJ.

J Gastrointest Surg. 2001 Jan-Feb;5(1):8-9. Review. No abstract available.

PMID:
11370619
3.

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1089-96.

PMID:
11072167
4.
5.

Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

You DD, Lee HG, Heo JS, Choi SH, Choi DW.

J Gastrointest Surg. 2009 Sep;13(9):1699-706. doi: 10.1007/s11605-009-0969-5. Epub 2009 Jul 7.

PMID:
19582512
6.

Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.

Cooperman AM, Snady H, Bruckner HW, Hammerman H, Siegel J, Stark B, Bank S.

Surg Clin North Am. 2001 Jun;81(3):699-708.

PMID:
11459283
7.

The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma.

Regine WF, John WJ, McGrath P, Strodel WE, Mohiuddin M.

J Hepatobiliary Pancreat Surg. 2000;7(1):53-7.

PMID:
10982592
8.

Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D.

Ann Surg Oncol. 1999 Jan-Feb;6(1):38-45.

PMID:
10030414
9.

[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].

Drudi F, Tassinari D, Giuliani J, Ridolfi C, Gianni L, Tamburini E, Fantini M, Santelmo C, Barzotti E, Lotti N, Ravaioli A.

Recenti Prog Med. 2013 Feb;104(2):80-5. doi: 10.1701/1241.13711. Review. Italian.

PMID:
23535964
10.

Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.

Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW.

Ann Surg Oncol. 2011 Dec;18(13):3615-22. doi: 10.1245/s10434-011-1847-4. Epub 2011 Jun 24.

PMID:
21701927
11.

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.

Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB.

Am J Surg. 1996 Jan;171(1):118-24; discussion 124-5.

PMID:
8554125
12.

[Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].

André T, Balosso J.

J Chir (Paris). 1999 Dec;136(6):309-17. Review. French.

PMID:
10675820
13.

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.

Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e.

PMID:
19092348
14.

[Chemotherapy in adenocarcinomas of the pancreas].

Huguier M.

Gastroenterol Clin Biol. 2002 Nov;26(11):1063; discussion 1063-4. French. No abstract available.

15.

Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.

Hardacre JM, Mulcahy M, Small W, Talamonti M, Obel J, Krishnamurthi S, Rocha-Lima CS, Safran H, Lenz HJ, Chiorean EG.

J Gastrointest Surg. 2013 Jan;17(1):94-100; discussion p. 100-1. doi: 10.1007/s11605-012-2064-6. Epub 2012 Nov 15.

PMID:
23229886
16.

Medical management of advanced gastric cancer.

Hill ME, Cunningham D.

Cancer Treat Rev. 1998 Apr;24(2):113-8. Review. No abstract available.

PMID:
9728421
17.

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.

Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB.

J Clin Oncol. 1998 Dec;16(12):3843-50.

PMID:
9850029
18.

Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.

Carducci MA, Abrams RA, Yeo CJ, Hruban RH, Zahurak ML, Cameron JL, Grochow LB.

Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):143-50.

PMID:
8641911
19.

Multimodality management of localized pancreatic cancer.

Wayne JD, Wolff RA, Pisters PW, Evans DB.

Cancer J. 2001 Jul-Aug;7 Suppl 1:S35-46. Review.

PMID:
11504284
20.

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.

Berardi R, Verdecchia L, Scartozzi M, Cascinu S.

JOP. 2005 Jan 13;6(1 Suppl):118-21. Review. No abstract available.

Supplemental Content

Support Center